NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 122 filers reported holding NURIX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,943 | +2159.8% | 1,265 | +2775.0% | 0.00% | – |
| Q2 2023 | $440 | +1660.0% | 44 | -98.0% | 0.00% | – |
| Q4 2022 | $25 | -99.9% | 2,250 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | +3.6% | 2,250 | +2.3% | 0.00% | – |
| Q2 2022 | $28,000 | -91.2% | 2,200 | -90.4% | 0.00% | -100.0% |
| Q1 2022 | $319,000 | – | 22,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 4,508,333 | $140,164,000 | 17.73% |
| Ponoi II Management, LLC | 686,274 | $21,336,000 | 16.34% |
| Column Group LLC | 5,383,333 | $167,368,000 | 16.04% |
| Ponoi Management, LLC | 686,274 | $21,336,000 | 12.55% |
| Foresite Capital Management IV, LLC | 1,238,456 | $38,504,000 | 4.61% |
| Foresite Capital Management V, LLC | 451,522 | $14,038,000 | 4.13% |
| WestHill Financial Advisors, Inc. | 283,333 | $8,809,000 | 3.13% |
| EcoR1 Capital, LLC | 2,019,019 | $62,771,000 | 2.78% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $39,929,000 | 2.26% |
| DAFNA Capital Management LLC | 306,320 | $9,523,000 | 2.26% |